RA Patients Taking Either 15 mg or 30 mg Dose of Upadacitinib Experience Improvement
Rheumatoid Arthritis Therapy Update: What’s Changed & What’s the Same
Clinicians Discuss Current & Future Rheumatoid Arthritis Approaches
Low-Dose Methotrexate Can Cause Adverse Effects
Catch Your Breath: Insights into ILD in RA Patients
Filgotinib Promising for RA
Case Report: RA Patient Suffers Methotrexate-Induced Cutaneous Lesions
RA Patients May Safely Stop Methotrexate in Tofacitinib Combination Therapy
Upadacitinib + Methotrexate & Other csDMARDs in RA Patients
- 1
- 2
- 3
- …
- 13
- Next Page »